Early procalcitonin to predict mortality in Critically ill COVID-19 patients: a multicentric cohort study.

MLA

Zattera, Luigi, et al. “Early Procalcitonin to Predict Mortality in Critically Ill COVID-19 Patients: A Multicentric Cohort Study.” Minerva Anestesiologica, vol. 88, no. 4, Apr. 2022, pp. 259–71. EBSCOhost, https://doi.org/10.23736/S0375-9393.22.15942-0.

APA

Zattera, L., Veliziotis, I., Benitez-Cano, A., Ramos, I., Larrañaga, L., Nuñez, M., Román, L., Adalid, I., Ferrando, C., Muñoz, G., Arruti, E., Minini, A., Bassas, E., Hernández, M., Taccone, F. S., Peluso, L., & Adalia, R. (2022). Early procalcitonin to predict mortality in Critically ill COVID-19 patients: a multicentric cohort study. Minerva Anestesiologica, 88(4), 259–271. https://doi.org/10.23736/S0375-9393.22.15942-0

Chicago

Zattera, Luigi, Ioannis Veliziotis, Adela Benitez-Cano, Isabel Ramos, Leire Larrañaga, Maria Nuñez, Lorena Román, et al. 2022. “Early Procalcitonin to Predict Mortality in Critically Ill COVID-19 Patients: A Multicentric Cohort Study.” Minerva Anestesiologica 88 (4): 259–71. doi:10.23736/S0375-9393.22.15942-0.